Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy
BackgroundExtended-release buprenorphine (BUP-XR) is a once-monthly subcutaneous injection for the treatment of opioid use disorder. Injection-site pain is a common adverse event reported with BUP-XR administration. Notwithstanding the advantages of BUP-XR, subjective pain and anxiety associated wit...
Saved in:
Main Authors: | Pouya Azar, Jane J. Kim, Ella Rohani, Dayyon Newman-Azar, Matin Narimani, Jessica Machado, Victor W. Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1500799/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01) -
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits
by: Mariya Masyukova, et al.
Published: (2025-02-01) -
Comparison of the effects of lidocaine and articaine used for buccal infiltration and supplemental palatinal infiltration anesthesia in maxillary molars with irreversible pulpitis: a prospective randomized study
by: Duygu Kolay, et al.
Published: (2025-02-01) -
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
by: Elenore P. Bhatraju, et al.
Published: (2025-01-01) -
Lidocaine Versus Ketamine Pretreatment on Propofol Injection Pain
by: Amir Murad Khudadad Boujan, et al.
Published: (2019-12-01)